Align Technology, Inc (ALGN) is a publicly traded company listed on the NASD. It operates in the Medical Instruments & Supplies industry, part of the broader Healthcare sector. The company has a market capitalization of 11.25B, generates annual revenue of 3.98B, and reports net income of 378.40M. As of the latest data, the stock is trading at 156.84 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. This stock does not currently pay a dividend. The stock exhibits higher volatility than the market, which may indicate greater risk and potential reward.
Analyst recommendation stands at Hold (3.87), indicating current market sentiment. Institutional ownership is reported at 97.93%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -33.01%, trading within a 52-week range of 122.00 - 246.19.
| Index: | S&P 500 | P/E: | 30.39 | EPS (ttm): | 5.16 | Insider Own: | 6.59% | Shs Outstand: | 72.04M | Perf Week: | 6.53% |
| Market Cap: | 11.25B | Forward P/E: | 14.34 | EPS next Y: | 10.94 | Insider Trans: | 0.16% | Shs Float: | 67.02M | Perf Month: | 15.60% |
| Income(ttm): | 378.40M | PEG: | 3.64 | EPS next Q: | 2.97 | Inst Own: | 97.93% | Short Float: | 4.47% | Perf Quarter: | 12.74% |
| Revenue(ttm): | 3.98B | P/S: | 2.83 | EPS this Y: | 9.20% | Inst Trans: | 2.54% | Short Ratio: | 2.17 | Perf Half Y: | -12.99% |
| Book/sh: | 54.93 | P/B: | 2.86 | EPS next Y: | 7.33% | ROA: | 6.01% | Short Interest: | 3.00M | Perf Year: | -33.01% |
| Cash/sh: | 14.00 | P/C: | 11.20 | EPS next 5Y: | 8.35% | ROE: | 9.58% | 52W Range: | 122.00 - 246.19 | Perf YTD: | -24.78% |
| Dividend Est.: | - | P/FCF: | 19.86 | EPS past 3/5Y: | -16.61% 0.33% | ROIC: | 9.36% | 52W High: | 246.19 -36.29% | Beta: | 1.83 |
| Dividend TTM: | - | Quick Ratio: | 1.17 | Sales past 3/5Y: | 0.39% 10.69% | Gross Margin: | 69.61% | 52W Low: | 122.00 28.56% | Perf 5Y: | -67.02% |
| Dividend Ex-Date: | - | Current Ratio: | 1.29 | EPS Y/Y TTM: | -12.05% | Oper. Margin: | 15.86% | RSI (14): | 73.03 | Volatility: | 2.93% 3.47% |
| Employees: | 20945 | Debt/Eq: | 0.03 | Sales Y/Y TTM: | 0.56% | Profit Margin: | 9.50% | Recom: | 1.94 | Target Price: | 179.08 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.02 | EPS Q/Q: | -49.48% | Payout: | 0.00% | Rel Volume: | 0.97 | Prev Close: | 155.00 |
| Sales Surprise: | 1.98% | EPS Surprise: | 8.61% | Sales Q/Q: | 1.82% | Earnings: | Oct 29 AMC | Avg Volume: | 1.38M | Price: | 156.84 |
| SMA20: | 10.51% | SMA50: | 15.38% | SMA200: | -2.32% | Undervalued: 14.18% | Volume: | 1,347,827 | Change: | 1.19% | |
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad's CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.